Academy of Managed Care Pharmacy 

San Antonio, USA | March 21-24, 2023

publication_icon

Disease severity and symptom control in patients with immunoglobulin A nephropathy: Results from a United States analysis of a real-world study

Richard Lafayette, Michel Kroes, Carolina Aldworth, Aneesh Thomas George, Briana Ndife, Jonathan DeCourcy, Emma Chatterton, Dario Roccatello

publication_icon

Impact of immunoglobulin A nephropathy on healthcare resource utilization in the United States: Results from a real-world study

Michel Kroes, Carolina Aldworth, Aneesh Thomas George, Briana Ndife, Jonathan DeCourcy, Keisha Golden, Richard Lafayette

publication_icon

Impact of immunoglobulin A nephropathy on work, productivity and activity impairment in the United States: Results from a real-world study

Briana Ndife, Michel Kroes, Carolina Aldworth, Aneesh Thomas George, Luis Prieto, Jonathan DeCourcy, Jade Garratt-Wheeldon, Richard Lafayette

publication_icon

Treatment patterns and outcomes in patients with immunoglobulin A nephropathy: Results from a United States data analysis of a real-world study

Richard Lafayette, Michel Kroes, Carolina Aldworth, Aneesh Thomas George, Briana Ndife, Jonathan DeCourcy, Keisha Golden, Dario Roccatello